Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Get a quick snapshot of today’s dividend ETF expense ratios and what they mean for your potential returns, with tips for comparing funds.
18,562 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Oil climbs above $95 as equities pause, with the S&P 500 near unchanged. Delta raises its Q1 revenue outlook, while t...
A high-profile export case links AI hardware, sanctions, and risk for investors. This article breaks down what happen...
Plug Power has captured attention as its revenue growth accelerates amid a reshaped hydrogen market. This article bre...
When a flagship endowment changes its crypto holdings, it offers a rare peek into risk management. This guide breaks ...
A Ripple-backed treasury firm says real banks are already using XRP on a daily basis, pushing XRP Ledger activity tow...
SpaceX’s IPO ignites a historic moment on Wall Street, lifting the SPCX stock at open and propelling Elon Musk into t...
The S&P 500 barely moved as traders waited for developments on Iran, keeping a cautious mood across equities and ener...
Tech founder moves set a high bar for OpenAI's IPO. This article breaks down the reality behind altman called openai ...
Nvidia surged into the spotlight as a long-term wealth engine for many investors. This guide asks the hard question: ...
Small, nearly unknown biotech stocks can surge when their pipeline milestones hit. This guide breaks down how to spot...
A major trading move shows Clearline Capital expanding its Core Scientific holding just as Bitcoin mining evolves int...